Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 May;8(3):225-33.
doi: 10.1023/a:1008883508462.

The development and validation of an instrument to assess acute sinus disease in children

Affiliations

The development and validation of an instrument to assess acute sinus disease in children

J M Garbutt et al. Qual Life Res. 1999 May.

Abstract

Our goal was to produce a reliable, responsive instrument to quantify disease burden in children with acute sinusitis for use in clinical trials. In a cross sectional survey of 1611 community pediatric patients, parents rated the burden attributable to 13 sinus symptoms. Using logistic regression, we identified five symptoms that predicted the clinical diagnosis of sinusitis. The S5 is the average symptom score for nasal obstruction, daytime and nighttime coughing, headache and colored nasal discharge (range 0-3). The S5 was high in children with acute sinusitis (mean = 1.54, SD = 0.77, N = 93), and low in well children (mean = 0.42, SD = 0.56, N = 1019). We assessed reliability and responsiveness of S5 in a prospective cohort study of 41 children with sinusitis. Parents completed a questionnaire at the office visit, at 12 h and 3, 7, 10 and 14 days. Intra-subject reliability at 12 h was excellent (ICC = 0.94). The S5 score was responsive in 24 patients followed for 14 days who improved (mean change = 1.52, SD = 0.12, p = 0.0062). The S5 score is standardized, reliable, responsive, easily obtained, and can be used to determine study eligibility and assess treatment effects without a physician's evaluation.

PubMed Disclaimer

References

    1. Ann Allergy Asthma Immunol. 1996 Sep;77(3):167-73; quiz 173-5 - PubMed
    1. Control Clin Trials. 1991 Aug;12(4 Suppl):142S-158S - PubMed
    1. J Chronic Dis. 1985;38(1):27-36 - PubMed
    1. Lancet. 1986 Feb 8;1(8476):307-10 - PubMed
    1. JAMA. 1998 Mar 18;279(11):875-7 - PubMed

Publication types

LinkOut - more resources